Arias Hugo R, McCardy Elizabeth A, Bayer Erin Z, Gallagher Martin J, Blanton Michael P
Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA.
Arch Biochem Biophys. 2002 Jul 1;403(1):121-31. doi: 10.1016/S0003-9861(02)00214-X.
Previous studies have established the presence of overlapping binding sites for the noncompetitive antagonists (NCAs) amobarbital, tetracaine, and 3-trifluoromethyl-3-(m-[(125)I]iodophenyl) diazirine ([(125)I]TID) within the ion channel of the Torpedo nicotinic acetylcholine receptor (AChR) in the resting state. These well-characterized NCAs and competitive radioligand binding and photolabeling experiments were employed to better characterize the interaction of the dissociative anesthetics ketamine and thienylcycloexylpiperidine (TCP) with the resting AChR. Our experiments yielded what appear to be conflicting results: (i) both ketamine and TCP potentiated [(125)I]TID photoincorporation into AChR subunits; and (ii) ketamine and TCP had very little effect on [(14)C]amobarbital binding. Nevertheless, (iii) both ketamine and TCP completely displaced [(3)H]tetracaine binding (K(i)s approximately 20.9 and 2.0 microM, respectively) by a mutually exclusive mechanism. To reconcile these results we propose that, in the resting ion channel, TCP and ketamine bind to a site that is spatially distinct from the TID and barbiturate locus, while tetracaine bridges both binding sites.
先前的研究已证实,在静息状态下,非竞争性拮抗剂(NCA)异戊巴比妥、丁卡因和3 - 三氟甲基 - 3 -(间 - [(125)I]碘苯基)二氮杂环丙烷([(125)I]TID)在电鳐烟碱型乙酰胆碱受体(AChR)的离子通道内存在重叠的结合位点。利用这些特征明确的NCA以及竞争性放射性配体结合和光标记实验,来更好地表征解离麻醉剂氯胺酮和噻吩环己基哌啶(TCP)与静息AChR的相互作用。我们的实验得出了看似相互矛盾的结果:(i)氯胺酮和TCP均增强了[(125)I]TID向AChR亚基的光掺入;以及(ii)氯胺酮和TCP对[(14)C]异戊巴比妥的结合影响很小。然而,(iii)氯胺酮和TCP均通过互斥机制完全取代了[(3)H]丁卡因的结合(抑制常数分别约为20.9和2.0微摩尔)。为了调和这些结果,我们提出,在静息离子通道中,TCP和氯胺酮结合到一个在空间上与TID和巴比妥酸盐位点不同的位点,而丁卡因则连接这两个结合位点。